Go Deep
Organogenesis Holdings Inc.
Organogenesis Holdings Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 24,424 | -1.5 | 0.54 | 0.23 | 115.23 |
| Oct 2026 | 24,489 | -1.4 | 0.51 | 0.23 | 108.24 |
| Oct 2026 | 24,517 | -1.4 | 0.50 | 0.23 | 105.41 |
| Oct 2026 | 24,619 | -1.2 | 0.45 | 0.23 | 94.69 |
| Oct 2026 | 24,600 | -1.2 | 0.46 | 0.23 | 96.71 |
| Oct 2026 | 24,600 | -1.2 | 0.46 | 0.23 | 96.71 |
| Oct 2026 | 24,627 | -1.2 | 0.44 | 0.23 | 93.76 |
| Oct 2026 | 24,591 | -1.2 | 0.46 | 0.23 | 97.22 |
Organogenesis Holdings Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 42,805,000.0 | 36,250,000.0 | 225,071,000.0 | 150,487,000.0 |
| Net Profit | -96,267,000.0 | -53,156,000.0 | 43,700,000.0 | 21,567,000.0 |
| EPS | -0.8 | -0.4 | 0.2 | 0.1 |
Organogenesis Holdings Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 563,030,000.0 | 482,043,000.0 | 433,140,000.0 | 450,893,000.0 | — |
| Net Profit | 37,032,000.0 | 861,000.0 | 4,945,000.0 | 15,532,000.0 | — |
| EPS | 0.2 | -0.0 | 0.0 | 0.1 | — |
Organogenesis Holdings Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 598,730,000.0 | 497,886,000.0 | 460,025,000.0 | 449,359,000.0 | — |
| Total Liabilities | 164,812,000.0 | 112,570,000.0 | 181,362,000.0 | 183,690,000.0 | — |
| Total Equity | 433,918,000.0 | 385,316,000.0 | 278,663,000.0 | 265,669,000.0 | — |
Owes vs Owns
Organogenesis Holdings Inc. owed $0.29 for every $1 it owned in Jun 2026, down from $0.41 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.29× | 0.28× | 0.23× | 0.39× | 0.41× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Organogenesis Holdings Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 15.6%Receivables 36.3%Inventory 4.9%Fixed assets (tangible) 26.6%Intangible assets 6.3%Other assets 10.1%
How it's funded — Dec 2025
Short-term debt 3.1%Long-term debt 10.6%Payables 5.3%Other liabilities 8.5%Shareholders' equity 72.5%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 93.7 | 135.6 | 103.8 | 102.5 |
| Receivables | 217.5 | 109.9 | 82.0 | 89.5 |
| Inventory | 29.6 | 26.2 | 28.3 | 24.8 |
| Fixed assets (tangible) | 159.5 | 126.2 | 156.3 | 145.7 |
| Intangible assets | 37.9 | 41.2 | 44.6 | 49.6 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 60.6 | 58.8 | 44.9 | 37.4 |
| Liabilities & equity | ||||
| Short-term debt | 18.6 | 9.1 | 5.5 | 4.5 |
| Long-term debt | 63.5 | 34.2 | 60.7 | 66.2 |
| Payables | 31.9 | 28.9 | 30.7 | 32.3 |
| Other liabilities | 50.7 | 40.3 | 84.4 | 80.6 |
| Shareholders' equity | 433.9 | 385.3 | 278.7 | 265.7 |
| Net tangible assets | 396.0 | 344.1 | 234.0 | 216.1 |
Organogenesis Holdings Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -10,309,000.0 | 14,208,000.0 | 30,917,000.0 | 24,859,000.0 | — |
| Investing Activities | -14,151,000.0 | -10,032,000.0 | -24,364,000.0 | -33,898,000.0 | — |
| Financing Activities | -17,360,000.0 | 27,637,000.0 | -5,505,000.0 | -2,199,000.0 | — |